MenB meningococcal disease outbreak in Kent
Public health teams in Kent are responding to cases of invasive meningococcal disease linked to an outbreak in Canterbury. This is a serious bacterial infection that can cause meningitis and septicaemia, and it can become life-threatening very quickly. UKHSA has said some cases were linked to visits to Club Chemistry in Canterbury between 5th and 7th March, and people who may have been exposed have been advised to come forward for preventative antibiotics.
Meningococcal disease can affect anyone, but teenagers and young adults are an important risk group because the infection spreads through close contact and early symptoms can be mistaken for flu, a virus, or even a hangover. The most important message is simple: know the signs, act quickly, and do not wait for a rash to appear before seeking help.
What meningococcal disease is
Meningitis is inflammation of the lining around the brain and spinal cord. It can be caused by viruses, bacteria and, more rarely, other organisms. Viral meningitis is generally less serious. Bacterial meningitis is less common, but it can develop into a medical emergency.
Meningococcal disease is caused by the bacterium Neisseria meningitidis. It can lead to meningitis, septicaemia, or both at the same time. Septicaemia means the bacteria have entered the bloodstream and can trigger sepsis. That is why meningococcal disease can escalate so fast.
Spot the signs and symptoms
Early symptoms can look like other common illnesses. They can include fever, headache, vomiting, muscle aches and tiredness. As the illness develops, symptoms may include a stiff neck, dislike of bright lights, confusion, drowsiness, cold hands and feet, and a rash that does not fade when pressed.
Not everyone gets every symptom. Symptoms can appear in any order. A rash may appear late, or not at all. That is why you should never wait for a rash before getting help.
In babies and very young children, signs can be less typical. They may seem very sleepy, irritable, hard to wake, floppy or unusually stiff. They may refuse feeds, vomit, or have a high-pitched cry.
When to get urgent help
Call 999 or go to A&E immediately if you think meningitis, septicaemia or sepsis could be possible. Do this even if you are not sure. The NHS advises people not to wait for all symptoms to appear and not to wait for a rash.
If you have already had advice but symptoms are getting worse, seek help again. If a friend, flatmate or family member seems unusually drowsy, confused, or difficult to wake, treat that as urgent.
How it spreads
Meningococcal bacteria spread through close contact with respiratory secretions. That can include coughing, kissing, or sharing items that transfer saliva. People can carry the bacteria in the back of the nose or throat without feeling unwell themselves.
That is one reason public health teams pay close attention to social networks, households, shared accommodation and student settings. Close mixing can increase the chance of spread, even when nobody initially realises there is a problem.
Why some people are being offered antibiotics
Preventative antibiotics are not for everyone. They are used for people who public health teams assess as having had relevant close exposure to a confirmed or likely case. The aim is to reduce the short-term risk of someone else becoming ill.
UKHSA guidance says chemoprophylaxis for close contacts should be given as quickly as possible, ideally within 24 hours. In UK practice, ciprofloxacin is commonly used because it can be given as a single dose.
If you have been contacted and told to take preventative antibiotics, follow that advice exactly. Even if you feel well, it is still important to take the medicine as directed.
How meningococcal disease is tested
If meningococcal disease is suspected in hospital, doctors will usually arrange to collect a range of samples. This would include blood, as well as possibly a throat swab or a sample of the spinal fluid ( cerebrospinal fluid , known as CSF). The biomedical scientists in the laboratory will try to grow the bacteria using special culture conditions or they might look for the genetic material of the bacteria, using the technique known as polymerase chain reaction (PCR).
Laboratory testing is important for two reasons. First, it helps clinical teams confirm what is causing the illness. Second, it helps public health teams understand whether cases are linked and what action may be needed for contacts and the wider community.
Specialist reference laboratories can carry out confirmatory testing and further characterisation of the bacteria which have been found in the meningococcal samples. This helps to see what strain of the Neisseria meningitidis the person has been infected with, which supports outbreak investigation, surveillance and public health decision-making.
How it is treated
If doctors suspect bacterial meningitis or meningococcal disease, treatment should begin urgently. People with suspected bacterial meningitis should receive intravenous antibiotics as soon as possible and within one hour of arriving at hospital.
In some circumstances, if there is likely to be a significant delay before reaching hospital, antibiotics may be given before transfer. The priority is to avoid delay in getting the person to emergency care.
This is why early recognition matters so much. Testing is important, but treatment cannot wait for laboratory confirmation if clinicians strongly suspect meningococcal disease.
Vaccination and protection
Vaccination protects against some important causes of meningitis, but not all meningitis. In the UK routine schedule, babies has been offered the MenB vaccine since 2015., alongside other vaccines that reduce the risk of serious infections such as Hib and pneumococcal disease. Teenagers are offered MenACWY vaccine, which protects against meningococcal groups A, C, W and Y. It does not protect against MenB, as this is considered to be a more serious risk in young children.
Laboratory scientists have now confirmed that a significant proportion of the cases in Kent are caused by the Men B strain of the bacterium. In the light of this, there will be a targeted vaccination campaign offering the vaccine against Men B for teenagers and young adults in that area.
It is important to note that it takes time for the immune system to respond to vaccines and give protection against the bacterium, so it is not a treatment. Also, everyone should keep up to date with vaccines against all types of meningitis. This applies especially for people under 25 who may have missed MenACWY before starting university.
Vaccination does not remove the need to recognise symptoms quickly. Someone who feels very unwell still needs urgent medical assessment.
The role of laboratories and public health teams
When a case is identified, clinicians, laboratories and health protection teams work together. Doctors diagnose and treat the patient. Scientific staff in laboratories use their skills and expertise to test samples and notify significant findings. Public health teams identify close contacts, arrange preventative antibiotics where needed, and assess whether there is evidence of a wider cluster or outbreak.
This coordinated response is essential. It helps protect the individual patient, supports rapid treatment, and reduces the risk of further cases in the community.
What people in Kent should do now
Stay alert to the symptoms of meningococcal disease, especially if you were in an affected setting or have been told you may have been exposed. Do not assume it is just flu. Do not wait for a rash.
If you have been contacted about preventative antibiotics, follow the advice you have been given. If you become unwell, seek urgent medical help immediately. If you are worried but it is not an emergency, NHS 111 can help direct you to the right service.
Meningococcal disease is rare, but it is serious. Fast recognition, urgent treatment, effective laboratory testing and timely public health action all make a difference.
We extend our deepest condolences to the families, friends and communities affected by the tragic deaths of young people from meningitis in Kent.
Biomedical scientists across hospital and reference laboratories have been working tirelessly to support the response. Their expertise has enabled the rapid identification of the strain of bacterium involved, which is crucial in guiding public health advice and treatment.
We are incredibly proud of their dedication and professionalism during such a difficult time, and grateful for the vital role they continue to play in helping bring this situation under control.
Dr Sarah Pitt, IBMS President, Virologist
Since the story broke, Dr Pitt has been undertaking national and regional media interviews to help inform the public about the outbreak and to highlight the vital work of biomedical scientists analysing patient samples.
